Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- EOLS
- Price
- 4.39
- Stock movement up
- +0.09 (2.09%)
- Company name
- Evolus Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 284.56M
- Ent value
- 488.79M
- Price/Sales
- 1.00
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -23.91%
- 1 year return (CAGR)
- -70.81%
- 3 year return (CAGR)
- -21.86%
- 5 year return (CAGR)
- -10.74%
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
EOLS does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.00 |
| Price to Book | - |
| EV to Sales | 1.71 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 64.82M |
| EPS (TTM) | -0.90 |
| FCF per share (TTM) | -0.87 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 285.82M |
| Gross profit (TTM) | 188.16M |
| Operating income (TTM) | -39.20M |
| Net income (TTM) | -58.56M |
| EPS (TTM) | -0.90 |
| EPS (1y forward) | -0.07 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 65.83% |
| Operating margin (TTM) | -13.71% |
| Profit margin (TTM) | -20.49% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 43.52M |
| Net receivables | 50.44M |
| Total current assets | 134.89M |
| Goodwill | 21.21M |
| Intangible assets | 48.72M |
| Property, plant and equipment | 16.93M |
| Total assets | 219.00M |
| Accounts payable | 22.96M |
| Short/Current long term debt | 154.89M |
| Total current liabilities | 66.71M |
| Total liabilities | 247.76M |
| Shareholder's equity | -28.76M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -50.28M |
| Capital expenditures (TTM) | 6.07M |
| Free cash flow (TTM) | -56.35M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -26.74% |
| Return on Invested Capital | -49.01% |
| Cash Return on Invested Capital | -47.16% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.35 |
| Daily high | 4.45 |
| Daily low | 4.25 |
| Daily Volume | 619K |
| All-time high | 38.49 |
| 1y analyst estimate | 15.17 |
| Beta | 1.01 |
| EPS (TTM) | -0.90 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| EOLS | S&P500 | |
| Current price drop from All-time high | -88.59% | -1.82% |
| Highest price drop | -92.41% | -56.47% |
| Date of highest drop | 29 Oct 2020 | 9 Mar 2009 |
| Avg drop from high | -68.88% | -10.84% |
| Avg time to new high | 101 days | 12 days |
| Max time to new high | 1935 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
284.56M
Marketcap category
Small-cap
Description
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Employees
329
Website
Investor relations
-
SEC filings
CEO
David Moatazedi
Country
USA
City
Newport Beach
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page